Evidence map›Paper›PMID 31239363›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

An alternative dogma on reduced artemisinin susceptibility: A new shadow from east to west.

Thirumalaisamy P Velavan, David Nderu, Tsiri Agbenyega, Francine Ntoumi, Peter G Kremsner

Abstract readLetterComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Putative molecular markers ofFrontiers in epidemiology · 2024
    Article
  5. Review
  6. Prevalence of Mutations in thePharmaceutics · 2021
    Article
  7. Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.International journal for parasitology. Drugs and drug resistance · 2021
    Article
  8. Article
  9. Article
  10. Reply to Velavan et al.: Polymorphisms ofProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Thirumalaisamy P VelavanInstitut für Tropenmedizin, Universitätsklinikum Tübingen, 72074 Tübingen, Germany; velavan@medizin.uni-tuebingen.de.ORCID 0000-0002-9809-9883
David NderuInstitut für Tropenmedizin, Universitätsklinikum Tübingen, 72074 Tübingen, Germany.
Tsiri AgbenyegaDepartment of Physiology, School of Medical Sciences, University of Science and Technology, 00233 Kumasi, Ghana.
Francine NtoumiInstitut für Tropenmedizin, Universitätsklinikum Tübingen, 72074 Tübingen, Germany.
Peter G KremsnerInstitut für Tropenmedizin, Universitätsklinikum Tübingen, 72074 Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ArtemisininsPlasmodium falciparum4-ButyrolactoneAcetogeninsMicrofilament ProteinsMutation4-ButyrolactoneAcetogeninsArtemisininscoronin acetogeninMicrofilament Proteins

Identifiers

PMID31239363
PMCPMC6601264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.